期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 44, 期 9, 页码 3394-3401出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2009.02.022
关键词
Integrin; RGD; Angiogenesis; Rhenium; Technetium; Cyclopeptide
资金
- Institut National du Cancer (INCa) [PL06-060]
We report the design of a new ligand of integrins that might be used for the molecular imaging of tumor neoangiogenesis. For this purpose, we designed a modified RGD tripeptide bearing a N-terminal N-bis(thioethyl)glycinate (NS2) motif and a thioethyl moiety at the C-terminus. Simultaneous coordination of an oxorhenium core by the NS2 and thioethyl moieties led to peptide cyclization and gave the corresponding monomers 13a and b (major isomer) resulting from the syn/anti-isomerism, along with dimers' species 16a and b. Cyclometallated peptide 13b showed the most promising activity with an IC50 of 86 nM for integrin alpha(V)beta(3) whereas it binds integrin a(IIb)beta(3) with an affinity lower by an order of magnitude. Labeling with [(99)mTc]oxotechnetium gluconate led exclusively to complex 17, the equivalent of compound 13b, which displayed satisfactory stabilities in mice plasma and towards glutathione. (C) 2009 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据